Evidence map›Paper›PMID 39985783›Full record

ArticleJournal of animal science2025

Xylo-oligosaccharides enhance intestinal and thymic immunity by modulating pyroptosis, gut microbiota, and Th17/Treg immune response in lipopolysaccharide-challenged piglets.

Weixiao Sun, Guangmang Liu, Fei Shen, De Wu, Yan Lin, Ruinan Zhang, Lianqiang Che, Bin Feng, Yong Zhuo, Shengyu Xu and 5 more

Abstract read
In one paragraph

Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Weixiao SunInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Guangmang LiuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.ORCID 0000-0003-2385-7528
Fei ShenInstitute of Environmental Sciences, Sichuan Agricultural University, Chengdu, China.
De WuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.ORCID 0000-0003-1873-9914
Yan LinInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Ruinan ZhangInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Lianqiang CheInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.ORCID 0000-0002-0940-7275
Bin FengInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.ORCID 0000-0001-6258-2729
Yong ZhuoInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.ORCID 0000-0002-8348-4199
Shengyu XuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Lun HuaInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Zhengfeng FangInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.ORCID 0000-0003-1844-194X
Xuemei JiangInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Jan LiInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
Jing WangMaize Research Institute, Sichuan Agricultural University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xylo-oligosaccharides (XOS) have been shown to improve the immune system of weaned piglets, but the molecular mechanism of their action remains unclear. Therefore, this study aimed to investigate the impact of XOS on intestinal and thymic immune function in weaned piglets challenged with lipopolysaccharide (LPS) and elucidate the underlying mechanism. In a 2 × 2 factorial arrangement, consisting of diet treatment (basal diet vs 0.02% XOS diet) and immunological challenge [saline vs LPS], 24 piglets were randomly divided into 4 groups (n = 6): CON group, basal diet + saline; LPS group, basal diet + LPS; XOS group, 0.02% XOS diet + saline; XOS_LPS group, 0.02% XOS diet + LPS. Piglets were fed either the basal or XOS diet for 21 d, followed by intraperitoneal injections of normal saline or LPS on the 22nd day. Ileum, thymus, and colon samples were collected 4 h after the intraperitoneal saline or LPS injection. The piglets fed the XOS diet had higher average daily feed intake and average daily weight gain (P < 0.05). The XOS diet increased ileal villus height and decreased crypt depth. XOS also enhanced ileal and thymic antioxidant enzyme activities, anti-inflammatory cytokine expression, and decreased malondialdehyde levels and mRNA abundance of pro-inflammatory cytokines in piglets (P < 0.05). The XOS diet also downregulated the ileal and thymic NOD-like receptor family pyrin domain containing 3 and gasdermin-D gene and protein expression associated with pyroptosis (P < 0.05). Moreover, The XOS diet increased the mRNA abundance of forkhead box P3, signal transducer and activator of transcription 5, and transforming growth factor beta 1 while decreasing signal transducer and activator of transcription 3 and retinoid-related orphan receptor-gammat mRNA abundance (P < 0.05). The XOS diet enhanced forkhead box P3 protein expression and reduced retinoid-related orphan receptor-gammat protein expression following the LPS challenge (P < 0.05). At the same time, The XOS diet affected the gut microbiota and increased levels of short-chain fatty acids (P < 0.05). In conclusion, XOS may modulate ileal and thymic immune function in weaned piglets following a 4-h LPS challenge by affecting gut microbiota, pyroptosis, and Th17/Treg immune responses.

Indexed as

Gastrointestinal MicrobiomeIntestinesOligosaccharidesPyroptosisThymus GlandAnimal FeedAnimalsDietGlucuronatesLipopolysaccharidesMaleSwineTh17 CellsT-Lymphocytes, RegulatoryGlucuronatesLipopolysaccharidesOligosaccharidesxylooligosaccharidegut microbiotaLPSpigletpyroptosisTh17/Treg immune responsexylo-oligosaccharides

Identifiers

PMID39985783
PMCPMC11926539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.